Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (41-50 of 244) with videos related to

Pageof 25
Sort By:
Plos One|February 6, 2014
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeAlexander Zoufaly, Alessandro Cozzi-Lepri, Joanne Reekie, et al.
BMC Medicine|May 30, 2018
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort studyCristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 11, 2019
Is the rate of virological failure to cART continuing to decline in recent calendar years?Stefano Rusconi, Maria M Santoro, Nicola Gianotti, et al.
AIDS (London, England)|October 4, 2008
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort studyAlessandro Cozzi-Lepri, Andrew N Phillips, Bonaventura Clotet, et al.
Plos One|November 24, 2011
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-scoreAlessandro Cozzi-Lepri, Mattia C F Prosperi, Jesper Kjær, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2016
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ARTNicola Squillace, Patrizia Lorenzini, Giuseppe Lapadula, et al.
Plos One|December 6, 2017
Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohortSilvia Nozza, Alessandro Cozzi-Lepri, Francesca Bai, et al.
BMC Infectious Diseases|February 14, 2014
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation studyGiulia Marchetti, Alessandro Cozzi-Lepri, Camilla Tincati, et al.
AIDS (London, England)|April 18, 2003
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimensMaria Paola Trotta, Adriana Ammassari, Alessandro Cozzi-Lepri, et al.
The Lancet. HIV|October 2, 2015
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort studyCristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Pageof 25

Showing results (41-50 of 244) with videos related to

Sort By:
Pageof 25
Plos One|February 6, 2014
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeAlexander Zoufaly, Alessandro Cozzi-Lepri, Joanne Reekie, et al.
BMC Medicine|May 30, 2018
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort studyCristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 11, 2019
Is the rate of virological failure to cART continuing to decline in recent calendar years?Stefano Rusconi, Maria M Santoro, Nicola Gianotti, et al.
AIDS (London, England)|October 4, 2008
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort studyAlessandro Cozzi-Lepri, Andrew N Phillips, Bonaventura Clotet, et al.
Plos One|November 24, 2011
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-scoreAlessandro Cozzi-Lepri, Mattia C F Prosperi, Jesper Kjær, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2016
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ARTNicola Squillace, Patrizia Lorenzini, Giuseppe Lapadula, et al.
Plos One|December 6, 2017
Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohortSilvia Nozza, Alessandro Cozzi-Lepri, Francesca Bai, et al.
BMC Infectious Diseases|February 14, 2014
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation studyGiulia Marchetti, Alessandro Cozzi-Lepri, Camilla Tincati, et al.
AIDS (London, England)|April 18, 2003
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimensMaria Paola Trotta, Adriana Ammassari, Alessandro Cozzi-Lepri, et al.
The Lancet. HIV|October 2, 2015
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort studyCristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Pageof 25